'' Cell IDx

Human Immune Subsets Panels Gallery

CD8, FoxP3, PD-1, CD4">

CD8, FoxP3, PD-1, CD4

Astrocytoma

CD8, FoxP3, PD-1, CD4 20x">

CD8, FoxP3, PD-1, CD4 20x

Astrocytoma

CD163, PD-L1, PanCK, CD68">

CD163, PD-L1, PanCK, CD68

Bladder Transitional Cell Carcinoma

CD163, PD-L1, PanCK, CD68 20x">

CD163, PD-L1, PanCK, CD68 20x

Bladder Transitional Cell Carcinoma

CD8, PD-L1, PanCK, CD68">

CD8, PD-L1, PanCK, CD68

Bladder Transitional Cell Carcinoma

CD8, PD-L1, PanCK, CD68 20x">

CD8, PD-L1, PanCK, CD68 20x

Bladder Transitional Cell Carcinoma

CD3, CD4, CD8, CD20">

CD3, CD4, CD8, CD20

Bladder Transitional Cell Carcinoma

CD3, CD4, CD8, CD20 20x">

CD3, CD4, CD8, CD20 20x

Bladder Transitional Cell Carcinoma

CD8, FoxP3, PD-1, CD4">

CD8, FoxP3, PD-1, CD4

Breast Invasive Ductal Carcinoma

CD8, FoxP3, PD-1, CD4 20x">

CD8, FoxP3, PD-1, CD4 20x

Breast Invasive Ductal Carcinoma

CD8, PD-L1, PanCK, CD68">

CD8, PD-L1, PanCK, CD68

Breast Invasive Ductal Carcinoma

CD8, PD-L1, PanCK, CD68 15x">

CD8, PD-L1, PanCK, CD68 15x

Breast Invasive Ductal Carcinoma

CD163, PD-L1, PanCK, CD68">

CD163, PD-L1, PanCK, CD68

Esophageal Squamous Cell Carcinoma

CD163, PD-L1, PanCK, CD68 20x">

CD163, PD-L1, PanCK, CD68 20x

Esophageal Squamous Cell Carcinoma

CD163, PD-L1, PanCK, CD68 20x. ROI-2.">

CD163, PD-L1, PanCK, CD68 20x

Esophageal Squamous Cell Carcinoma

CD8, PD-L1, PD-1, CD68">

CD8, PD-L1, PD-1, CD68

Esophageal Squamous Cell Carcinoma

CD8, PD-L1, PD-1, CD68 20x">

CD8, PD-L1, PD-1, CD68 20x

Esophageal Squamous Cell Carcinoma

CD163, PD-L1, PanCK, CD68">

CD163, PD-L1, PanCK, CD68

Head & Neck Nasopharyngeal Carcinoma

CD163, PD-L1, PanCK, CD68 20x">

CD163, PD-L1, PanCK, CD68 20x

Head & Neck Nasopharyngeal Carcinoma

CD3, CD4, CD8, CD20">

CD3, CD4, CD8, CD20

Head & Neck Nasopharyngeal Carcinoma

CD3, CD4, CD8, CD20 20x">

CD3, CD4, CD8, CD20 20x

Head & Neck Nasopharyngeal Carcinoma

PanCK, PD-L1, CD68, CD163 (1).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PanCK, PD-L1, CD68, CD163 (1)

Head & Neck Squamous Cell Carcinoma

PanCK, PD-L1, CD68, CD163 (2).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PanCK, PD-L1, CD68, CD163 (2)

Head & Neck Squamous Cell Carcinoma

PanCK, PD-L1, CD68, CD163 (3).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PanCK, PD-L1, CD68, CD163 (3)

Head & Neck Squamous Cell Carcinoma

PanCK, PD-L1, CD68, CD163 (4).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PanCK, PD-L1, CD68, CD163 (4)

Head & Neck Squamous Cell Carcinoma

PanCK, PD-L1, CD68, CD163 (5).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PanCK, PD-L1, CD68, CD163 (5)

Head & Neck Squamous Cell Carcinoma

PD-L1, CD163.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PD-L1, CD163

Head & Neck Squamous Cell Carcinoma

PD-L1, CD68, CD163.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PD-L1, CD68, CD163

Head & Neck Squamous Cell Carcinoma

PD-L1, CD68.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

PD-L1, CD68

Head & Neck Squamous Cell Carcinoma

CD8, PD-1.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD8, PD-1

Head & Neck Squamous Cell Carcinoma

CD4, PD-1.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, PD-1

Head & Neck Squamous Cell Carcinoma

CD4, FoxP3.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, FoxP3

Head & Neck Squamous Cell Carcinoma

CD4, CD8, FoxP3, PD-1.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, CD8, FoxP3, PD-1

Head & Neck Squamous Cell Carcinoma

CD4, CD8, CD20, FoxP3 (1).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, CD8, CD20, FoxP3 (1)

Head & Neck Squamous Cell Carcinoma

CD4, CD8, CD20, FoxP3 (2).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, CD8, CD20, FoxP3 (2)

Head & Neck Squamous Cell Carcinoma

CD4, CD8, CD20, FoxP3 (3).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, CD8, CD20, FoxP3 (3)

Head & Neck Squamous Cell Carcinoma

CD4, CD8, CD20, FoxP3 (4).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, CD8, CD20, FoxP3 (4)

Head & Neck Squamous Cell Carcinoma

CD4, CD8, CD20, FoxP3 (5).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD4, CD8, CD20, FoxP3 (5)

Head & Neck Squamous Cell Carcinoma

CD8, CD68, PD-1, PD-L1.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

CD8, CD68, PD-1, PD-L1

Head & Neck Squamous Cell Carcinoma

CD3, CD4, CD8, CD20 (1).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV-, CD3, CD4, CD8, CD20 (1)

Head & Neck Squamous Cell Carcinoma

CD3, CD4, CD8, CD20 (2).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV-, CD3, CD4, CD8, CD20 (2)

Head & Neck Squamous Cell Carcinoma

CD3, CD4, CD8, CD20 (3).
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV-, CD3, CD4, CD8, CD20 (3)

Head & Neck Squamous Cell Carcinoma

CD3, CD4, CD8, CD20. 2-panel overlay,
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV+, CD3, CD4, CD8, CD20

Head & Neck Squamous Cell Carcinoma

CD3, CD4, CD8, CD20.
Tissue courtesy of Dr. Mark Lingen, University of Chicago.">

HPV+, CD3, CD4, CD8, CD20

Head & Neck Squamous Cell Carcinoma

CD8, PD-L1, PD-1, CD68">

CD8, PD-L1, PD-1, CD68

Hodgkin’s Lymphoma

CD8, PD-L1, PD-1, CD68 20x">

CD8, PD-L1, PD-1, CD68 20x

Hodgkin’s Lymphoma

CD3, CD4, CD8, CD20">

CD3, CD4, CD8, CD20

Hodgkin’s Lymphoma

CD3, CD4, CD8, CD20 10x">

CD3, CD4, CD8, CD20 10x

Hodgkin’s Lymphoma

CD3, CD4, CD8, CD20 20x">

CD3, CD4, CD8, CD20 20x

Hodgkin’s Lymphoma

CD4, CD8, FoxP3, Tbet">

CD4, CD8, FoxP3, Tbet

Human Tonsil

CD68, CD8, CD56, GranzymeB">

CD68, CD8, CD56, GranzymeB

Human Tonsil

Ki-67, CD8, CD4, CD31 5x">

Ki-67, CD8, CD4, CD31 5x

Human Tonsil

Ki-67, CD8, CD4, CD31 20x">

Ki-67, CD8, CD4, CD31 20x

Human Tonsil

CD4, CD8, CD20, CD68">

CD4, CD8, CD20, CD68

Human Tonsil

PD-1, PD-L1, CD8, CD68">

PD-1, PD-L1, CD8, CD68

Human Tonsil

PDL1, IDO, CD163, CD68 (1)">

PDL1, IDO, CD163, CD68 (1)

Human Tonsil

PDL1, IDO, CD163, CD68 (2)">

PDL1, IDO, CD163, CD68 (2)

Human Tonsil

CD8, FoxP3, PD-1, CD4">

CD8, FoxP3, PD-1, CD4

Intestine, Rectum – Adenocarcinoma

CD8, FoxP3, PD-1, CD4 20x">

CD8, FoxP3, PD-1, CD4 20x

Intestine, Rectum – Adenocarcinoma

CD8, FoxP3, Tbet, CD4">

CD8, FoxP3, Tbet, CD4

Intestine, Rectum – Adenocarcinoma

CD8, FoxP3, Tbet, CD4 20x">

CD8, FoxP3, Tbet, CD4 20x

Intestine, Rectum – Adenocarcinoma

CD8, FoxP3, Tbet, CD4 20x. ROI-2.">

CD8, FoxP3, Tbet, CD4 20x

Intestine, Rectum – Adenocarcinoma

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)">

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)

Luminal B Breast Cancer

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)">

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)

Luminal B Breast Cancer

CD4, CD8, FoxP3, Tbet">

CD4, CD8, FoxP3, Tbet

Luminal B Breast Cancer

CD68, CD163, PanCK, PD-L1.
Tissue courtesy of Dr. Jair Bar, Sheba Medical Center.">

CD68, CD163, PanCK, PD-L1

Lung Cancer

CD3, CD4, CD8, CD20.
Tissue courtesy of Dr. Jair Bar, Sheba Medical Center.">

CD3, CD4, CD8, CD20

Lung Cancer

CD8, FoxP3, CD3, CD4">

CD8, FoxP3, CD3, CD4

Lymph Node – Anaplastic Large Cell Lymphoma

CD8, FoxP3, CD3, CD4 20x">

CD8, FoxP3, CD3, CD4 20x

Lymph Node – Anaplastic Large Cell Lymphoma

CD8, FoxP3, CD3, CD4 20x. ROI-2.">

CD8, FoxP3, CD3, CD4 20x

Lymph Node – Anaplastic Large Cell Lymphoma

CD8, PD-L1, PD-1, CD68">

CD8, PD-L1, PD-1, CD68

Lymph Node – Anaplastic Large Cell Lymphoma

CD8, PD-L1, PD-1, CD68 20x">

CD8, PD-L1, PD-1, CD68 20x

Lymph Node – Anaplastic Large Cell Lymphoma

CD4, CD8, FoxP3, Tbet">

CD4, CD8, FoxP3, Tbet

Melanoma

CD8, FoxP3, CD3, CD4">

CD8, FoxP3, CD3, CD4

Ovary – Endometrioid Adenocarcinoma

CD8, FoxP3, CD3, CD4 20x">

CD8, FoxP3, CD3, CD4 20x

Ovary – Endometrioid Adenocarcinoma

CD8, FoxP3, CD3, CD4 20x. ROI-2.">

CD8, FoxP3, CD3, CD4 20x

Ovary – Endometrioid Adenocarcinoma

CD3, CD4, CD8, FoxP3">

CD3, CD4, CD8, FoxP3

Pancreatic Ductal Adenocarcinoma

CD20, CD68, PD-1, PD-L1">

CD20, CD68, PD-1, PD-L1

Pancreatic Ductal Adenocarcinoma

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)">

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (1)

Triple-Negative Breast Cancer

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)">

CD3, CD4, CD8, CD20, T4-Cells, T8-Cells (2)

Triple-Negative Breast Cancer

CD3, CD4, CD8, CD68, FoxP3, PD-1. 2-panel overlay.">

CD3, CD4, CD8, CD68, FoxP3, PD-1

Triple-Negative Breast Cancer

CD3, CD4, CD8, CD20 (1)">

CD3, CD4, CD8, CD20 (1)

Triple-Negative Breast Cancer

CD3, CD4, CD8, CD20 (2)">

CD3, CD4, CD8, CD20 (2)

Triple-Negative Breast Cancer

CD3, CD4, CD8, CD20 (3)">

CD3, CD4, CD8, CD20 (3)

Triple-Negative Breast Cancer

CD3, CD4, CD8, CD20 (1)">

CD3, CD4, CD8, CD20 (1)

Triple-Negative Breast Cancer

CD8, FoxP3, PD-1, PD-L1 (1)">

CD8, FoxP3, PD-1, PD-L1 (1)

Triple-Negative Breast Cancer

CD8, FoxP3, PD-1, PD-L1 (2)">

CD8, FoxP3, PD-1, PD-L1 (2)

Triple-Negative Breast Cancer

CD8, FoxP3, PD-1, PD-L1 (3)">

CD8, FoxP3, PD-1, PD-L1 (3)

Triple-Negative Breast Cancer

CD8, CD68, PD-1, PD-L1 (1)">

CD8, CD68, PD-1, PD-L1 (1)

Triple-Negative Breast Cancer

CD8, CD68, PD-1, PD-L1 (2)">

CD8, CD68, PD-1, PD-L1 (2)

Triple-Negative Breast Cancer

CD8, CD68, PD-1, PD-L1 (3)">

CD8, CD68, PD-1, PD-L1 (3)

Triple-Negative Breast Cancer

CD4, CD8, CD68, FoxP3">

CD4, CD8, CD68, FoxP3

Triple-Negative Breast Cancer

CD4, CD8, FoxP3, Tbet">

CD4, CD8, FoxP3, Tbet

Triple-Negative Breast Cancer

Ki67, CD8, CD4, CD31 5x">

Ki67, CD8, CD4, CD31 5x

Triple-Negative Breast Cancer

Ki67, CD8, CD4, CD31 20x">

Ki67, CD8, CD4, CD31 20x

Triple-Negative Breast Cancer

CD3, PD-1, PD-L1">

CD3, PD-1, PD-L1

Triple-Negative Breast Cancer

Cell IDx is a Registered Supplier on and

© 2016–22 Cell IDx. Cell IDx, UltraPlex, UltraPolymer, UltraTag, and Path IDx are trademarks of Cell IDx, Inc. All Rights Reserved. Privacy Policy | Terms of Service Website by Fifth Street Design.

Your cart

Total

USD

Shipping and discount codes are added at checkout.